Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications

被引:91
作者
Grassi, Guido [1 ,2 ]
Seravalle, Gino [3 ]
Mancia, Giuseppe [1 ,3 ]
机构
[1] Univ Milano Bicocca, Dipartimento Sci Salute, Med Clin, I-20052 Milan, Italy
[2] Sesto San Giovanni, IRCCS Multimed, Milan, Italy
[3] Ist Auxol Italiano, Milan, Italy
关键词
Congestive heart failure; drug treatment; hypertension; myocardial infarction; prognosis; sympathetic nervous system; AUTONOMIC NERVOUS-SYSTEM; BLOOD-PRESSURE; HEART-FAILURE; PLASMA NOREPINEPHRINE; BAROREFLEX FUNCTION; RENAL DENERVATION; SENSITIVITY; MOXONIDINE; MORTALITY; RESPONSES;
D O I
10.1111/eci.12553
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The sympathetic nervous exerts a key role in cardiovascular homeostasis control by regulating cardiac output, systemic vascular resistance, heart rate and blood pressure. Materials and methods Data collected during the past 30 years have unequivocally shown that in a considerable number of cardiovascular as well as noncardiovascular disease there is a marked activation of the sympathetic nervous system which exerts in the long-term period unfavourable haemodynamic, metabolic, cardiovascular and renal effects. Results This paper will review the current knowledge on the alterations in sympathetic function described in cardiovascular disease, with particular focus on hypertension, heart failure and myocardial infarction. Conclusions The consequences of the phoenomenon will be discussed together with its therapeutic implications. This will be done by examining the impact of nonpharmacological as well as pharmacological interventions on sympathetic cardiovascular drive. The effects of new invasive approaches, such as carotid baroreceptor stimulation as well as renal nerves ablation, will be also briefly discussed.
引用
收藏
页码:1367 / 1375
页数:9
相关论文
共 43 条
  • [1] Increased Sympathetic Nerve Activity in COPD is Associated with Morbidity and Mortality
    Andreas, Stefan
    Haarmann, Helge
    Klarner, Stephan
    Hasenfuss, Gerd
    Raupach, Tobias
    [J]. LUNG, 2014, 192 (02) : 235 - 241
  • [2] Nonselective versus selective β-adrenergic receptor blockade in congestive heart failure -: Differential effects on sympathetic activity
    Azevedo, ER
    Kubo, T
    Mak, S
    Al-Hesayen, A
    Schofield, A
    Allan, R
    Kelly, S
    Newton, GE
    Floras, JS
    Parker, JD
    [J]. CIRCULATION, 2001, 104 (18) : 2194 - 2199
  • [3] Increased muscle sympathetic nerve activity predicts mortality in heart failure patients
    Barretto, Antonio C. P.
    Santos, Amilton C.
    Munhoz, Robinson
    Rondon, Maria U. P. B.
    Franco, Fabio G.
    Trombetta, Ivani C.
    Roveda, Fabiana
    de Matos, Luciana N. J.
    Braga, Ana M. W.
    Middlekauff, Holly R.
    Negrao, Carlos E.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (03) : 302 - 307
  • [4] Pharmacological properties of indapamide - Rationale for use in hypertension
    Bataillard, A
    Schiavi, P
    Sassard, J
    [J]. CLINICAL PHARMACOKINETICS, 1999, 37 (Suppl 1) : 7 - 12
  • [5] A Controlled Trial of Renal Denervation for Resistant Hypertension
    Bhatt, Deepak L.
    Kandzari, David E.
    O'Neill, William W.
    D'Agostino, Ralph
    Flack, John M.
    Katzen, Barry T.
    Leon, Martin B.
    Liu, Minglei
    Mauri, Laura
    Negoita, Manuela
    Cohen, Sidney A.
    Oparil, Suzanne
    Rocha-Singh, Krishna
    Townsend, Raymond R.
    Bakris, George L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (15) : 1393 - 1401
  • [6] Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension Results From the Double-Blind, Randomized, Placebo-Controlled Rheos Pivotal Trial
    Bisognano, John D.
    Bakris, George
    Nadim, Mitra K.
    Sanchez, Luis
    Kroon, Abraham A.
    Schafer, Jill
    de Leeuw, Peter W.
    Sica, Domenic A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (07) : 765 - 773
  • [7] PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE
    COHN, JN
    LEVINE, TB
    OLIVARI, MT
    GARBERG, V
    LURA, D
    FRANCIS, GS
    SIMON, AB
    RECTOR, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) : 819 - 823
  • [8] Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)
    Cohn, JN
    Pfeffer, MA
    Rouleau, J
    Sharpe, N
    Swedberg, K
    Straub, M
    Wiltse, C
    Wright, TJ
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (05) : 659 - 667
  • [9] DiNicolantonio JJ, 2015, OPEN HEART, V21
  • [10] REGIONAL NOREPINEPHRINE TURNOVER IN HUMAN HYPERTENSION
    ESLER, M
    LAMBERT, G
    JENNINGS, G
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1989, 11 : 75 - 89